Indeed, significant improvements in survival outcomes in either squamous or non-squamous NSCLC [vs. chemotherapy in second line (7–10) and in first line only for patients with high expression of PD-L1 (11)] were observed. Here, CD274 is linked to non-small cell lung carcinoma.